What do policy makers need to know? Lessons from the decision to add pneumococcal conjugate and rotavirus vaccines to the US immunization program. [electronic resource]
- Vaccine Jul 2013
- C6-7 p. digital
Publication Type: Journal Article
1873-2518
10.1016/j.vaccine.2013.05.051 doi
Advisory Committees Centers for Disease Control and Prevention, U.S. Cost-Benefit Analysis Decision Making Evidence-Based Practice Health Policy Humans Immunization Programs--economics Pneumococcal Vaccines Rotavirus Vaccines United States Vaccines, Conjugate